Magnesium Carbonate

Magnesium carbonate is an inorganic magnesium salt (MgCO3) that acts as a phosphate binder in the gastrointestinal tract by forming insoluble magnesium phosphate complexes, preventing phosphate absorption. It is primarily used in clinical settings for managing hyperphosphatemia in chronic kidney disease and hemodialysis patients.

Origin & History

Magnesium carbonate (MgCO₃) is an inorganic mineral salt that occurs naturally in magnesite ore or is produced synthetically through precipitation from magnesium salts and sodium carbonate. It is extracted through mining, crushing, and purification of natural deposits or created through laboratory chemical reactions.

Historical & Cultural Context

No evidence of traditional medicinal use exists in herbal, Ayurvedic, or other historical systems. Biomedical applications are entirely modern, beginning in the 1990s specifically for renal phosphate control in dialysis patients.

Health Benefits

• Effectively controls serum phosphate levels in hemodialysis patients without causing hypercalcemia (Strong evidence: multiple RCTs, PMID: 8770963, 18193489)
• Reduces calcium intake burden by 48% compared to calcium acetate while maintaining phosphate control (Moderate evidence: RCT n=32, PMID: 17971314)
• Allows higher vitamin D (calcitriol) dosing without hypercalcemia risk (Strong evidence: crossover trial, PMID: 8770963)
• May prevent progression of coronary artery calcification in dialysis patients (Preliminary evidence: pilot study n=11, PMID: 19469885)
• Provides non-inferior phosphate control to sevelamer-HCl at 80% lower cost (Moderate evidence: large trial referenced in PMID: 26069822)

How It Works

Magnesium carbonate dissociates in the acidic environment of the stomach, releasing Mg2+ ions that bind dietary phosphate to form insoluble magnesium phosphate (Mg3(PO4)2), which is excreted in feces rather than absorbed. This reduces intestinal phosphate transport mediated by sodium-phosphate cotransporters (NaPi-IIb) in the small intestine. Unlike calcium-based binders, magnesium carbonate does not contribute to calcium loading, avoiding activation of the calcium-sensing receptor (CaSR) pathways that can suppress PTH and cause hypercalcemia.

Scientific Research

Clinical evidence comes primarily from trials in hemodialysis and chronic kidney disease patients, including a 6-month RCT (n=40, PMID: 18193489) and crossover study (n=14, PMID: 8770963) demonstrating effective phosphate control. A pilot trial (n=32, PMID: 17971314) showed 70.6% of patients met phosphate targets with significantly reduced calcium intake.

Clinical Summary

Multiple randomized controlled trials, including studies indexed under PMID 8770963 and PMID 18193489, demonstrate that magnesium carbonate effectively reduces serum phosphate in hemodialysis patients to levels comparable to calcium acetate. One RCT (n=32) found magnesium carbonate reduced elemental calcium intake burden by approximately 48% versus calcium acetate while maintaining equivalent phosphate control. Evidence is strongest for the hyperphosphatemia indication, with moderate-to-strong support from multiple RCTs; however, evidence for general magnesium supplementation efficacy relative to other forms such as magnesium glycinate or citrate is limited. Long-term cardiovascular and mortality outcome data specific to magnesium carbonate as a phosphate binder remain an area of ongoing investigation.

Nutritional Profile

Magnesium Carbonate (MgCO3) is an inorganic mineral salt, not a macronutrient source. It contains no protein, fat, carbohydrates, or fiber. Primary active component is elemental magnesium at approximately 28-29% by molecular weight (MgCO3 molecular weight: 84.31 g/mol; Mg atomic weight: 24.31 g/mol). A typical supplemental dose of 400-500mg MgCO3 yields approximately 115-145mg elemental magnesium. As a carbonate salt, it also releases carbon dioxide (CO2) and carbonate/bicarbonate ions upon contact with gastric acid, which may contribute mild antacid activity. Contains no vitamins, amino acids, or organic bioactive compounds. Bioavailability: Magnesium from carbonate salts is considered moderately bioavailable; absorption estimated at 30-40% under normal gastric acid conditions, occurring primarily in the small intestine via both active (TRPM6/TRPM7 channels) and passive paracellular transport. Bioavailability is reduced in achlorhydria or with proton pump inhibitor use due to dependence on acidic environment for ionization. Compared to magnesium oxide (~4% bioavailability) it performs better, but is less bioavailable than magnesium citrate (~90%) or magnesium glycinate. Basic magnesium carbonate (hydrated form: 4MgCO3·Mg(OH)2·4H2O) contains approximately 40% elemental magnesium by weight and is the more commonly used commercial form. No caloric value; negligible osmotic load at standard doses.

Preparation & Dosage

Clinically studied doses range from 86 mg elemental magnesium per dose, titrated individually up to several grams daily for phosphate control. Typically combined with calcium carbonate in ratios of 86:100 mg (Mg:Ca). Used with low dialysate magnesium (0.6 mg/dL) to prevent hypermagnesemia. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Calcium carbonate, vitamin D (calcitriol), low-magnesium dialysate, phosphate-restricted diet

Safety & Interactions

The most common side effects are gastrointestinal, including diarrhea, loose stools, and nausea, owing to the osmotic and neutralizing properties of the carbonate anion. Hypermagnesemia is a serious risk in patients with impaired renal function, as magnesium is renally cleared; serum magnesium must be monitored in dialysis populations using this agent. Magnesium ions can chelate and reduce the absorption of tetracycline antibiotics, fluoroquinolones, bisphosphonates, and levothyroxine, requiring dosing separation of at least two hours. Magnesium carbonate is generally avoided in patients with severe renal insufficiency not on dialysis, and safety data in pregnancy are insufficient to establish a formal recommendation beyond standard magnesium dietary requirements.